SEC Form 4 · accession 0001237899-18-000021
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher R. Fenimore
Officer — VP Controller
Period of report
Dec 12, 2018
Accepted (ET)
Dec 14, 2018 · 4:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 30, 2018 | G | 50 | $0.00 | D | 1,421 | D | |
| Common Stock | Dec 12, 2018 | A | 5,000 | $0.00 | A | 6,421 | D | |
| Common StockF2 | Aug 30, 2018 | G | 50 | $0.00 | A | 4,347 | I | By Trust |
| Common StockF2 | Oct 25, 2018 | G | 2,950 | $0.00 | D | 1,397 | I | By Trust |
| Common Stock | Oct 25, 2018 | G | 2,950 | $0.00 | A | 2,950 | I | by 2018 GRAT |
| Common Stock | holding | — | — | — | 1,349 | I | By 401(k) Plan | |
| Common Stock | holding | — | — | — | 1,424 | I | by 2017 GRAT |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F3 | $381.40 | Dec 12, 2018 | A | 11,400 | A | — | Dec 12, 2028 | Common Stock | 11,400 | 11,400 | D |
Explanation of responses
- F1Award of Restricted Stock under the Amended and Restated 2014 Long-Term Incentive Plan that vests in its entirety on December 12, 2023.
- F2These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
- F3The stock option award vests in four equal annual installments, commencing one year after the date of grant.